Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 31 studies | 33% ± 16% | |
fibroblast | 21 studies | 27% ± 12% | |
pericyte | 19 studies | 29% ± 15% | |
microglial cell | 14 studies | 41% ± 12% | |
oligodendrocyte | 13 studies | 39% ± 14% | |
astrocyte | 13 studies | 40% ± 16% | |
macrophage | 13 studies | 33% ± 15% | |
glutamatergic neuron | 12 studies | 57% ± 23% | |
smooth muscle cell | 12 studies | 28% ± 9% | |
GABAergic neuron | 11 studies | 54% ± 23% | |
oligodendrocyte precursor cell | 11 studies | 43% ± 16% | |
neuron | 9 studies | 42% ± 20% | |
epithelial cell | 9 studies | 30% ± 12% | |
B cell | 7 studies | 21% ± 5% | |
myeloid cell | 7 studies | 23% ± 4% | |
endothelial cell of lymphatic vessel | 7 studies | 31% ± 13% | |
natural killer cell | 7 studies | 22% ± 5% | |
capillary endothelial cell | 6 studies | 25% ± 10% | |
myofibroblast cell | 6 studies | 27% ± 13% | |
interneuron | 6 studies | 68% ± 18% | |
retinal ganglion cell | 6 studies | 34% ± 16% | |
amacrine cell | 6 studies | 35% ± 13% | |
retina horizontal cell | 6 studies | 34% ± 14% | |
adipocyte | 6 studies | 23% ± 5% | |
dendritic cell | 6 studies | 27% ± 5% | |
monocyte | 6 studies | 27% ± 8% | |
connective tissue cell | 6 studies | 26% ± 9% | |
mast cell | 5 studies | 24% ± 5% | |
ciliated cell | 5 studies | 28% ± 7% | |
endothelial cell of vascular tree | 5 studies | 30% ± 20% | |
club cell | 5 studies | 29% ± 10% | |
type I pneumocyte | 5 studies | 28% ± 10% | |
type II pneumocyte | 5 studies | 25% ± 9% | |
progenitor cell | 4 studies | 38% ± 10% | |
granule cell | 4 studies | 42% ± 9% | |
retinal bipolar neuron | 4 studies | 25% ± 11% | |
cardiac muscle cell | 4 studies | 18% ± 1% | |
vein endothelial cell | 4 studies | 34% ± 19% | |
lymphocyte | 4 studies | 30% ± 9% | |
CD8-positive, alpha-beta T cell | 4 studies | 19% ± 2% | |
chondrocyte | 4 studies | 41% ± 8% | |
T cell | 4 studies | 22% ± 5% | |
basal cell | 4 studies | 33% ± 19% | |
goblet cell | 4 studies | 32% ± 26% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 1% | |
conventional dendritic cell | 3 studies | 22% ± 8% | |
hematopoietic precursor cell | 3 studies | 28% ± 8% | |
non-classical monocyte | 3 studies | 22% ± 6% | |
glomerular endothelial cell | 3 studies | 19% ± 1% | |
neural crest cell | 3 studies | 17% ± 1% | |
GABAergic interneuron | 3 studies | 60% ± 5% | |
glial cell | 3 studies | 36% ± 10% | |
plasma cell | 3 studies | 34% ± 3% | |
CD4-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
endothelial cell of artery | 3 studies | 23% ± 5% | |
mononuclear phagocyte | 3 studies | 23% ± 4% | |
GABAergic amacrine cell | 3 studies | 47% ± 14% | |
OFF-bipolar cell | 3 studies | 32% ± 11% | |
ON-bipolar cell | 3 studies | 36% ± 14% | |
glycinergic amacrine cell | 3 studies | 42% ± 11% | |
retinal rod cell | 3 studies | 22% ± 5% | |
rod bipolar cell | 3 studies | 27% ± 12% | |
Schwann cell | 3 studies | 32% ± 17% | |
regulatory T cell | 3 studies | 19% ± 3% | |
hepatocyte | 3 studies | 34% ± 16% | |
ependymal cell | 3 studies | 42% ± 14% | |
leukocyte | 3 studies | 28% ± 6% | |
alveolar macrophage | 3 studies | 31% ± 8% | |
transit amplifying cell | 3 studies | 41% ± 27% | |
mesothelial cell | 3 studies | 29% ± 7% | |
mural cell | 3 studies | 45% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2100.32 | 1445 / 1445 | 100% | 14.08 | 183 / 183 |
breast | 100% | 2805.23 | 459 / 459 | 100% | 16.16 | 1117 / 1118 |
lung | 100% | 2710.46 | 578 / 578 | 100% | 9.25 | 1153 / 1155 |
prostate | 100% | 2642.93 | 245 / 245 | 100% | 13.42 | 500 / 502 |
brain | 100% | 2170.29 | 2631 / 2642 | 100% | 12.32 | 705 / 705 |
uterus | 100% | 4136.84 | 170 / 170 | 99% | 11.69 | 455 / 459 |
ovary | 100% | 3072.89 | 180 / 180 | 99% | 6.80 | 426 / 430 |
thymus | 100% | 2144.28 | 652 / 653 | 99% | 11.12 | 599 / 605 |
bladder | 100% | 2512.81 | 21 / 21 | 99% | 9.66 | 497 / 504 |
stomach | 100% | 1769.17 | 359 / 359 | 98% | 12.93 | 281 / 286 |
intestine | 100% | 2706.54 | 966 / 966 | 98% | 11.62 | 517 / 527 |
pancreas | 96% | 941.47 | 314 / 328 | 99% | 10.01 | 177 / 178 |
kidney | 100% | 1404.52 | 89 / 89 | 95% | 8.17 | 856 / 901 |
adrenal gland | 100% | 1576.81 | 258 / 258 | 94% | 9.26 | 217 / 230 |
skin | 100% | 2206.03 | 1808 / 1809 | 94% | 11.96 | 442 / 472 |
liver | 100% | 873.88 | 226 / 226 | 86% | 4.39 | 350 / 406 |
blood vessel | 100% | 2601.95 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 11.61 | 29 / 29 |
spleen | 100% | 2560.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.97 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.93 | 1 / 1 |
adipose | 100% | 2494.54 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1441.11 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1093.60 | 845 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 2029.78 | 824 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 71% | 4.49 | 57 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0006281 | Biological process | DNA repair |
GO_0051301 | Biological process | cell division |
GO_0008283 | Biological process | cell population proliferation |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0007064 | Biological process | mitotic sister chromatid cohesion |
GO_0000775 | Cellular component | chromosome, centromeric region |
GO_0005694 | Cellular component | chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PDS5B |
Protein name | Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3) PDS5 cohesin associated factor B |
Synonyms | APRIN KIAA0979 AS3 |
Description | FUNCTION: Regulator of sister chromatid cohesion in mitosis which may stabilize cohesin complex association with chromatin. May couple sister chromatid cohesion during mitosis to DNA replication. Cohesion ensures that chromosome partitioning is accurate in both meiotic and mitotic cells and plays an important role in DNA repair. Plays a role in androgen-induced proliferative arrest in prostate cells. . |
Accessions | Q9NTI5 ENST00000450460.5 [Q9NTI5-2] ENST00000315596.15 [Q9NTI5-1] ENST00000447833.1 A9IYQ1 |